Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Debt / NOTE 2.500% 9/1
-
Market price (% of par)
-
98.67%
-
Total 13F principal
-
$57,640,000
-
Principal change
-
+$1,040,000
-
Total reported market value
-
$64,618,581
-
Number of holders
-
8
-
Value change
-
+$1,020,671
-
Number of buys
-
3
-
Number of sells
-
1
Institutional Holders of TRAVERE THERAPEUTICS INC - NOTE 2.500% 9/1 as of Q1 2025
As of 31 Mar 2025,
TRAVERE THERAPEUTICS INC - NOTE 2.500% 9/1 was held by
8 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$57,640,000
in principal (par value) of the bond.
The largest 8 bondholders included
CSS LLC/IL, Indaba Capital Management, L.P., DeepCurrents Investment Group LLC, LAZARD ASSET MANAGEMENT LLC, OAKTREE CAPITAL MANAGEMENT LP, Russell Investments Group, Ltd., Jefferies Financial Group Inc., and Context Capital Management, LLC.
This page lists
8
institutional bondholders reporting positions
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.